Close Menu

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 30 employees in the third quarter, the company said in a regulatory document this week.

PerkinElmer said that its management approved a plan during the quarter to shift some of its R&D resources into a newly opened Center for Innovation, resulting in the layoffs. It added in its quarterly financial document filed with the US Securities and Exchange Commission that all employees were notified of their termination by Sept. 29.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.